Pig Kidney Transplants Gain Momentum as Organ Shortage Persists

Xenotransplantation offers a potential path forward for kidney failure patients facing years on transplant waiting lists.

The National Kidney Foundation reports that more than 90,000 people in the United States have kidney failure. Many require dialysis treatment while awaiting organ donations, a process that can take years.

Xenotransplantation involves surgically implanting an organ from one species into a recipient of another species. Researchers have focused on pig kidneys as viable candidates, as porcine organs share structural and functional similarities with human kidneys. Surgical teams have conducted initial procedures using genetically modified pig kidneys, with several recipients surviving beyond the transplant operation.

Advocates for the procedure point to the persistent gap between available donor organs and patients awaiting transplants. In 2025, approximately 3,500 kidney transplants occurred in the United States, while the waiting list continued to grow.

Researchers have developed pigs with genetic modifications designed to prevent organ rejection, a major barrier in xenotransplantation. These modifications reduce proteins that trigger the recipient's immune system to attack the foreign organ.

The procedure remains experimental. Federal regulators have approved limited clinical trials, and patients receiving xenotransplants undergo intensive monitoring. Researchers continue studying long-term outcomes and potential complications, including the risk of cross-species viral transmission.

Medical centers participating in xenotransplant trials have outlined eligibility criteria for recipients. Candidates typically have end-stage kidney disease and cannot access traditional transplants. Patients must commit to rigorous follow-up care and immunosuppressive medication regimens.

The National Institutes of Health, the Food and Drug Administration, and private research organizations have funded xenotransplantation research. Universities and transplant centers have established collaborative programs to advance the field.

Dialysis, the standard treatment for kidney failure, requires patients to undergo sessions multiple times weekly for several hours. Transplantation, whether from deceased donors, living donors, or through xenotransplantation, can reduce or eliminate the need for dialysis.

Xenotransplantation does not resolve the need for traditional organ donations. Instead, researchers view it as an additional tool to expand the available organ supply and reduce wait times.